The administration of mesenchymal stem cells (MSCs) as a therapy for liver disease holds
great promise. MSCs can differentiate into hepatocytes, reduce liver inflammation, promote …

Mesenchymal stromal/stem cells (MSCs) are multipotent adult stem cells that support
homeostasis during tissue regeneration. In the last decade, cell therapies based on the use …

Liver dysfunctions are classified into acute and chronic diseases, which comprise a
heterogeneous group of pathological features and a high mortality rate. Liver transplantation …

Hepatic fibrosis/cirrhosis is a significant health burden worldwide, resulting in liver failure or
hepatocellular carcinoma (HCC) and accounting for many deaths each year. The …

The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver
fibrosis is predominantly based on their immunosuppressive properties, and their ability to …

Recently, mesenchymal stromal cells (MSCs) and their derivative exosome have become a
promising approach in the context of liver diseases therapy, in particular, acute liver failure …

Mesenchymal stem cells (MSCs) secrete paracrine factors that play crucial roles during
tissue regeneration. An increasing body of evidence suggests that this paracrine function is …

The liver, a component of the gastrointestinal tract, is one of the most important organs in the
human body. The liver performs over 500 functions to promote physiological homeostasis. In …

Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can
progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing …

Mesenchymal stem cells (MSCs) may have potential applications in regenerative medicine
for the treatment of chronic liver diseases (CLDs). Human menstrual blood is a novel source …